Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
CONTINUING EDUCATION • 2 HOURS / 2 CEUS
Your Clients Are Talking About Psychedelics.
Are You Prepared?
Psychedelics 101: Foundations for Ethical Care,
Harm Reduction & Integration
Friday, November 20, 2026 11 a.m.-1 p.m. CST • Online via Zoom
Psychedelics are prompting a significant paradigm shift in psychiatry, bringing expanded consciousness, subjective experience, and meaning into conversations about treatment. Clinicians need a framework for responding safely and ethically even when psychedelic therapy is outside their usual practice. Led by three specialists in psychedelic-assisted and ketamine-assisted psychotherapy, this introduction explores the medicines, professional boundaries, and foundational approaches to preparation and integration. Includes time for Q&A.
LEARNING OBJECTIVES
Describe the current landscape of psychedelic care across the U.S., including emerging clinical models and differing legal contexts.
Identify key medicines, their effects and contexts of use, distinguish prescribed treatment from harm reduction for naturalistic use while staying within one's scope of practice.
Identify preparation approaches, describe therapeutic presence during dosing, and explain how integration builds on existing clinical skills.
Explain the importance of clinician self-regulation, consent, and power dynamics.
CONTINUING EDUCATION • 2 HOURS / 2 CEUS
Your Clients Are Talking About Psychedelics.
Are You Prepared?
Psychedelics 101: Foundations for Ethical Care,
Harm Reduction & Integration
Friday, November 20, 2026 11 a.m.-1 p.m. CST • Online via Zoom
Psychedelics are prompting a significant paradigm shift in psychiatry, bringing expanded consciousness, subjective experience, and meaning into conversations about treatment. Clinicians need a framework for responding safely and ethically even when psychedelic therapy is outside their usual practice. Led by three specialists in psychedelic-assisted and ketamine-assisted psychotherapy, this introduction explores the medicines, professional boundaries, and foundational approaches to preparation and integration. Includes time for Q&A.
LEARNING OBJECTIVES
Describe the current landscape of psychedelic care across the U.S., including emerging clinical models and differing legal contexts.
Identify key medicines, their effects and contexts of use, distinguish prescribed treatment from harm reduction for naturalistic use while staying within one's scope of practice.
Identify preparation approaches, describe therapeutic presence during dosing, and explain how integration builds on existing clinical skills.
Explain the importance of clinician self-regulation, consent, and power dynamics.